SCHEMBL4380922

SCHEMBL4380922

CCc1c(OCc2ccccc2)cc(OCc2ccccc2)c(-c2cccc(OC)c2)c1Cc1nn(CCO)c(=O)o1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.41
MGLL Q99685 2/20 0.41
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
SLC16A3 O15427 6/20 0.37
SLC16A1 P53985 6/20 0.37
MCTS1 Q9ULC4 3/20 0.37
GSK3B P49841 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
BCHE P06276 1/20 0.36
LIPC P11150 1/20 0.36
ACHE P22303 1/20 0.36
LIPE Q05469 1/20 0.36
KMT2A Q03164 1/20 0.36
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ERN1 O75460 1/20 0.35
VDR P11473 1/20 0.35
ASAH1 Q13510 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4388883 0.92 MAOB (0.37) FAAHMGLLGSK3BCDK5CDK5R1
SCHEMBL4384187 0.85 FAAH (0.36) FAAHMGLLMTNR1AMTNR1BGSK3B
SCHEMBL4380795 0.84 FAAH (0.38) FAAHMGLLMTNR1AMTNR1BGSK3B
SCHEMBL4396313 0.82 MAOB (0.38) FAAHMGLLBCHELIPCACHE
SCHEMBL4380441 0.81 MTNR1B (0.37) MTNR1AMTNR1B
SCHEMBL4387544 0.75 KDM4C (0.33)
SCHEMBL4388215 0.75 FAAH (0.38) FAAHMGLLMTNR1AMTNR1BBCHE
SCHEMBL4384028 0.71 NOTUM (0.42) GSK3BCDK5CDK5R1
SCHEMBL4383920 0.69 MAOB (0.41) GSK3BCDK5CDK5R1BCHEKMT2A
SCHEMBL4381051 0.69 MAOB (0.41) GSK3BCDK5CDK5R1BCHEKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P FAAH 3872/4885MGLL 4472/4885MTNR1A 2061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.